Use of TNF (tumour necrosis factor)-Blocking Therapy in Combination With DMARDs in Patients With Early Rheumatoid Arthritis.
Phase of Trial: Phase IV
Latest Information Update: 29 Nov 2017
At a glance
- Drugs Infliximab (Primary) ; Hydroxychloroquine; Methotrexate; Prednisone; Sulfasalazine
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 13 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.
- 01 Aug 2013 Results published in the Annals of the Rheumatic Diseases.
- 30 Jun 2012 Results published in Annals of the Rheumatic Diseases.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History